KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (Weighted Average) (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $496.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.49% to $496.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $496.4 million through Dec 2025, changed 0.49% year-over-year, with the annual reading at $496.4 million for FY2025, 0.49% changed from the prior year.
  • Shares Outstanding (Weighted Average) hit $496.4 million in Q4 2025 for Elanco Animal Health, roughly flat from $496.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $496.8 million in Q3 2025 to a low of $486.7 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $491.4 million across 5 years, with a median of $492.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 20.5% in 2021 and later rose 0.23% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $487.2 million in 2021, then grew by 0.23% to $488.3 million in 2022, then rose by 0.82% to $492.3 million in 2023, then increased by 0.35% to $494.0 million in 2024, then grew by 0.49% to $496.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ELAN at $496.4 million in Q4 2025, $496.8 million in Q3 2025, and $495.9 million in Q2 2025.